| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34,631 |
25,045 |
$2.00M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,474 |
16,322 |
$1.52M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15,454 |
11,283 |
$1.33M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,831 |
4,593 |
$170K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,260 |
1,288 |
$137K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,355 |
604 |
$105K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,313 |
5,314 |
$103K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,046 |
2,454 |
$70K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,531 |
1,337 |
$39K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
8,821 |
7,362 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
630 |
539 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
145 |
137 |
$17K |
| 90834 |
Psychotherapy, 45 minutes with patient |
140 |
78 |
$10K |
| 81002 |
|
3,084 |
1,609 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
505 |
247 |
$6K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
19 |
12 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
33 |
25 |
$3K |
| 87634 |
|
40 |
40 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
404 |
257 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
43 |
40 |
$2K |
| 96127 |
|
228 |
190 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
493 |
411 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
41 |
30 |
$705.37 |
| 81025 |
|
77 |
37 |
$597.50 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
27 |
27 |
$437.43 |
| 81003 |
|
266 |
195 |
$400.81 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
276 |
139 |
$393.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
662 |
399 |
$355.72 |
| 99000 |
|
119 |
102 |
$274.82 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
178 |
144 |
$136.83 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$134.78 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
19 |
17 |
$130.32 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
66 |
45 |
$14.95 |
| 3078F |
|
59 |
58 |
$0.00 |
| 3074F |
|
209 |
197 |
$0.00 |
| 3079F |
|
15 |
14 |
$0.00 |